Similarities between induced membrane and amniotic membrane: Novelty for bone repair

Archive ouverte

Gindraux, Florelle | Rondot, Thomas | de Billy, Benoit | Zwetyenga, Narcisse | Fricain, Jean-Christophe | Pagnon, Aurélie | Obert, Laurent

Edité par CCSD ; Elsevier -

IF 2.759. International audience. Previous clinical studies have shown the efficacy of a two-stage surgical procedure - the induced membrane (IM) technique - for reconstruction of large bone defects or bone non-union. The first stage involves radical debridement and insertion of a cement spacer into the bone defect. The second stage, performed weeks to months later, consists of removing the spacer while leaving the foreign body membrane induced by the cement in place, and then filling the cavity with bone autograft. The IM has been shown to (1) act as a protective physical barrier by preventing bone autograft resorption and (2) act as a bioreactor by promoting healing through revascularisation and growth factor secretion, and by concentrating mesenchymal stem cells (MSC) with osteogenic properties. New solutions to reduce this surgical procedure to a single step are being explored, for example by using an IM-like bioactive and protective barrier inserted into the bone defect at the same time as bone graft.

Consulter en ligne

Suggestions

Du même auteur

Fresh and in vitro osteodifferentiated human amniotic membrane, alone or associated with an additional scaffold, does not induce ectopic bone formation in Balb/c mice.

Archive ouverte | Laurent, Romain | CCSD

IF 1.331. International audience. The human amniotic membrane (hAM) has been successfully used as a natural carrier containing amniotic mesenchymal stromal cells, epithelial cells and growth factors. It has a little...

In vitro osteodifferentiation of intact human amniotic membrane is not beneficial in the context of bone repair

Archive ouverte | Gualdi, Thomas | CCSD

International audience

Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study

Archive ouverte | Odet, Stéphane | CCSD

International audience. Medication-related osteonecrosis of the jaw (MRONJ) is a complication of certain pharmacological treatments such as bisphosphonates, denosumab, and angiogenesis inhibitors. There are currentl...

Chargement des enrichissements...